Metasphere Labs Inc.
LABZ
CNSX
04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
---|---|---|---|---|---|
Net Income | -405.11% | -130.74% | 91.63% | 99.97% | 97.73% |
Total Depreciation and Amortization | -89.28% | 168.22% | -61.83% | -69.95% | -78.95% |
Total Amortization of Deferred Charges | -76.30% | -76.30% | -76.30% | -76.30% | 68.08% |
Total Other Non-Cash Items | -27.54% | -39.14% | -92.06% | -91.89% | -90.10% |
Change in Net Operating Assets | 62.11% | -9.12% | -844.23% | -538.83% | -413.18% |
Cash from Operations | -99.57% | -356.21% | -54.85% | 46.96% | 72.84% |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -100.00% |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | 103.86% |
Cash from Investing | -- | -- | -- | -- | 213.91% |
Total Debt Issued | -- | -- | -101.75% | -100.00% | -108.56% |
Total Debt Repaid | -4,614.81% | -357.96% | -412.63% | -595.49% | 97.43% |
Issuance of Common Stock | 34.45% | 47.93% | 533.53% | 484.39% | 205.25% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 33.63% | 27.12% | 84.07% | 22.60% | -32.45% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | 100.00% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -164.26% | -163.85% | 648.67% | 1,823.08% | 119.64% |